The Pulse Newsletter
HCMA travels to policy conference
Last week, I had the privilege to moderate a panel, “Novel Nursing: Helping Patients Adapt to Medical Innovation,” on the challenges and opportunities created by Myosin Inhibitors in Hypertrophic Cardiomyopathy at the PACH Cardiovascular Health Policy Summit in Washington DC. I was joined by Sue Philpott, RN, BSN – Corewell Health in Grand Rapids, MI, and Amy Beatty…
Read MoreThe University of Colorado Hospital – Aurora, CO
The University of Colorado is one of our newest HCMA Recognized Centers of Excellence. The UCHealth Team is honored to be recognized and work in partnership with the HCMA to genuinely provide the highest standard of care for patients with Hypertrophic Cardiomyopathy. The mission of the University of Colorado’s HCM Program is to improve the lives of patients with HCM by providing first-class medical care to patients and their…
Read MoreVolunteer!
Volunteers significantly contribute to the success of the Hypertrophic CardiomyopathyAssociation and our commitment to providing support, education, advocacy, andadvancement of research, understanding, and care to those with HCM. Our volunteer’stireless dedication gives an extra hand needed to make our communities healthcareexperiences positive. To learn more about HCMA volunteer opportunities and getinvolved, click here. HCMA Volunteer…
Read MoreHCM Medications
Sabrina Cuddy May is about medical management here at the HCMA. Medical management means using medications and other non-invasive therapies to treat disease and relieve symptoms. It’s exciting that new treatments for HCM are being studied and that the FDA approved Camzyos last year! It is historic for treatments to be targeted for HCM. HCM…
Read More